Lilly Pulitzer is serving up a Valentine’s Day partnership with Lele Sadoughi, the New York-based accessories brand. Marking ...

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

Senior equity analysts at StockNews.com upgraded Eli Lilly (LLY, Financial) stock from 'hold' to 'buy' as its stock has shifted positively. Analysts say the upgrade is a sign of increased ...

It won the Pulitzer Prize in 2020. Now comes a film version of the book, directed and written (with Joslyn Barnes) by Ross, whose only previous feature is the luminous 2018 documentary “Hale ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Novo and Lilly have both been on a manufacturing expansion tear in 2024, lining up multiple high-profile production projects around the world. To name just a few investments, Novo has blueprinted ...

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation.

Gary Cohn, a longtime journalist who won a Pulitzer Prize as a reporter for The Baltimore Sun, died Dec. 23 at 72 after collapsing at a Los Angeles-area bookstore following a boxing class.

Gary Cohn, 72, formerly of Philadelphia, an Inquirer alum who went on to win a Pulitzer Prize at the Baltimore Sun during a decades-long career devoted to investigative reporting, died Monday, Dec. 23 ...

Instead of going for a swim, Dianne Buswell slipped into swimwear to enjoy a sauna with her father. The Strictly Come Dancing star shared a peek of her turquoise scoop-neck swimsuit, which she ...

Tech entrepreneur and Tesla (TSLA, Financials) CEO Elon Musk's disclosure of using weight-loss pharmaceuticalsincluding Eli Lilly's (LLY, Financials) Mounjaro and Novo Nordisk's Ozempichas drawn ...

In the time since, though, some analysts have said the reaction is overblown, particularly for weight-loss drugmakers like Wegovy, and Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly.